Du Kuo, Farhood Anwar, Jaeschke Hartmut
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
Department of Pathology, St. David's North Austin Medical Center, Austin, TX, USA.
Arch Toxicol. 2017 Feb;91(2):761-773. doi: 10.1007/s00204-016-1692-0. Epub 2016 Mar 22.
Acetaminophen (APAP) hepatotoxicity is characterized by an extensive mitochondrial oxidant stress. However, its importance as a drug target has not been clarified. To investigate this, fasted C57BL/6J mice were treated with 300 mg/kg APAP and the mitochondria-targeted antioxidant Mito-Tempo (MT) was given 1.5 h later. APAP caused severe liver injury in mice, as indicated by the increase in plasma ALT activities and centrilobular necrosis. MT dose-dependently reduced the injury. Importantly, MT did not affect APAP-protein adducts formation, glutathione depletion or c-jun N-terminal kinase activation and its mitochondrial translocation. In contrast, hepatic glutathione disulfide and peroxynitrite formation were dose-dependently reduced by MT, indicating its effective mitochondrial oxidant stress scavenging capacity. Consequently, mitochondrial translocation of Bax and release of mitochondrial intermembrane proteins such as apoptosis-inducing factor were prevented, and nuclear DNA fragmentation was eliminated. To demonstrate the importance of mitochondria-specific antioxidant property of MT, we compared its efficacy with Tempo, which has the same pharmacological mode of action as MT but lacks the mitochondria targeting moiety. In contrast to the dramatic protection by MT, the same molar dose of Tempo did not significantly reduce APAP hepatotoxicity. In contrast, even a 3 h post-treatment with MT reduced 70 % of the injury, and the combination of MT with N-acetylcysteine (NAC) provided superior protection than NAC alone. We conclude that MT protects against APAP overdose in mice by attenuating the mitochondrial oxidant stress and preventing peroxynitrite formation and the subsequent mitochondrial dysfunction. MT is a promising therapeutic agent for APAP overdose patients.
对乙酰氨基酚(APAP)肝毒性的特征是广泛的线粒体氧化应激。然而,其作为药物靶点的重要性尚未明确。为了对此进行研究,对禁食的C57BL/6J小鼠给予300mg/kg的APAP,并在1.5小时后给予线粒体靶向抗氧化剂Mito-Tempo(MT)。APAP导致小鼠严重肝损伤,血浆谷丙转氨酶(ALT)活性升高和小叶中心坏死表明了这一点。MT呈剂量依赖性地减轻了损伤。重要的是,MT不影响APAP-蛋白质加合物的形成、谷胱甘肽耗竭或c-jun氨基末端激酶激活及其线粒体易位。相反,MT呈剂量依赖性地减少了肝脏中谷胱甘肽二硫化物和过氧亚硝酸盐的形成,表明其具有有效的线粒体氧化应激清除能力。因此,Bax的线粒体易位以及凋亡诱导因子等线粒体外膜蛋白的释放被阻止,并且核DNA片段化被消除。为了证明MT线粒体特异性抗氧化特性的重要性,我们将其疗效与Tempo进行了比较,Tempo与MT具有相同的药理作用模式,但缺乏线粒体靶向部分。与MT的显著保护作用相反,相同摩尔剂量的Tempo并未显著降低APAP肝毒性。相比之下,即使在MT治疗3小时后,损伤也减少了70%,并且MT与N-乙酰半胱氨酸(NAC)联合使用提供了比单独使用NAC更好的保护作用。我们得出结论,MT通过减轻线粒体氧化应激并防止过氧亚硝酸盐形成及随后的线粒体功能障碍来保护小鼠免受APAP过量的影响。MT是一种有前途的用于APAP过量患者的治疗药物。